Ambien Related Published Studies
Well-designed clinical trials related to Ambien (Zolpidem)
Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial. [2011.07]
The use of a non-benzodiazepine hypnotic sleep-aid (Zolpidem) in patients undergoing ACL reconstruction: a randomized controlled clinical trial. [2011.05]
Zolpidem and zopiclone impair similarly monotonous driving performance after a single nighttime intake in aged subjects. [2011.04]
Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. [2011.02.01]
A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia. [2011.01]
Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial. [2011.01]
Comparing effects of clonazepam and zolpidem on sleep quality of patients on
maintenance hemodialysis. [2011]
A double-blind, randomized, comparative study to evaluate the efficacy and safety
of zaleplon versus zolpidem in shortening sleep latency in primary insomnia. [2011]
Alterations in cyclic alternating pattern associated with phase advanced sleep are differentially modulated by gaboxadol and zolpidem. [2010.11]
Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep. [2010.11]
Zolpidem for persistent vegetative state--a placebo-controlled trial in pediatrics. [2010.10]
Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial. [2010.09]
Sublingual zolpidem in early onset of sleep compared to oral zolpidem: polysomnographic study in patients with primary insomnia. [2010.06]
Modafinil and zolpidem use by emergency medicine residents. [2009.12]
Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers. [2009.07]
Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder. [2009.06]
Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem. [2009.06]
Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. [2009.06]
Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial. [2009.05]
Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age. [2009.05]
A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. [2009.05]
Improvement of idiopathic central sleep apnea with zolpidem. [2009.04.15]
Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects. [2009.02]
Zolpidem extended-release 12.5 mg associated with improvements in work performance in a 6-month randomized, placebo-controlled trial. [2008.10.01]
Hypnotherapy in the treatment of chronic combat-related PTSD patients suffering from insomnia: a randomized, zolpidem-controlled clinical trial. [2008.07]
A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. [2008.06.15]
Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. [2008.01.01]
Efficacy and Safety of Zolpidem Extended Release in Elderly Primary Insomnia Patients. [2008.01]
A randomized, controlled prospective trial of zolpidem and haloperidol for use as sleeping agents in pediatric burn patients. [2008.01]
Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate. [2008.01]
Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude. [2007.11.01]
Acute effects of zolpidem on daytime alertness, psychomotor and physical performance. [2007.11]
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. [2007.07]
Pharmacokinetic and pharmacodynamic interactions between zolpidem and caffeine. [2007.07]
Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. [2007.03.13]
Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo. [2006.12]
Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening. [2006.10.15]
A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers. [2006.06]
Prior sleep with zolpidem enhances the effect of caffeine or modafinil during 18 hours continuous work. [2006.05]
Zolpidem reduces postoperative pain, fatigue, and narcotic consumption following knee arthroscopy: a prospective randomized placebo-controlled double-blinded study. [2006.04]
Zolpidem extended-release. [2006]
Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement. [2005.08]
Acute neurophysiological effects of the hypnotic zolpidem in healthy volunteers. [2005.05]
Daytime sleep and performance following a zolpidem and melatonin cocktail. [2005.01.01]
Temporal changes in postural sway caused by ultrashort-acting hypnotics: triazolam and zolpidem. [2005]
Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. [2004.10]
Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. [2004.08]
Zolpidem is not superior to temazepam with respect to rebound insomnia: a controlled study. [2004.08]
Zolpidem and memory: a study using the process-dissociation procedure. [2004.07]
Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m. [2004]
Effects of after-midnight intake of zolpidem and temazepam on driving ability in women with non-organic insomnia. [2003.11]
Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg. [2003.07]
Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. [2003.07]
Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study. [2002.01]
Effectiveness and tolerability of melatonin and zolpidem for the alleviation of jet lag. [2001.07]
A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects. [2001.06]
A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia. [2001.05]
Eight weeks of non-nightly use of zolpidem for primary insomnia. [2000.12.15]
Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia. [2000.12.15]
Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem. [2000.12]
Comparative tolerability, pharmacodynamics, and pharmacokinetics of a metabolite of a quinolizinone hypnotic and zolpidem in healthy subjects. [2000.12]
The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance. [2000.08]
Comparison of the effects of zolpidem and triazolam on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers. [2000.08]
[The effect of zolpidem on EEG activity in falling asleep process] [2000.07]
Differential impairment of triazolam and zolpidem clearance by ritonavir. [2000.06.01]
Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance. [2000.06]
Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. [2000.05]
Effects of zolpidem and zopiclone on cognitive and attentional function in young healthy volunteers: an event-related potential study. [2000.02]
Zolpidem and promethazine in pre-anaesthetic medication. A pharmacopsychological approach. [2000]
Zolpidem for persistent insomnia in SSRI-treated depressed patients. [1999.10]
A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. [1999.09]
Triazolam and zolpidem: effects on human memory and attentional processes. [1999.05]
Coadministration of short-term zolpidem with sertraline in healthy women. [1999.02]
Zolpidem, a valuable alternative to benzodiazepine hypnotics for chronic insomnia? [1999]
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole. [1998.12]
Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. [1998.11]
Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man. [1998.07]
The abuse potential of zolpidem administered alone and with alcohol. [1998.05]
Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem. [1998.04]
Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory. [1998.04]
Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study. [1998.01]
Rifampin reduces plasma concentrations and effects of zolpidem. [1997.12]
Triazolam and zolpidem: a comparison of their psychomotor, cognitive, and subjective effects in healthy volunteers. [1997.11]
[Optimizing anesthesiologic premedication with reference to biopsychological theories. Exemplified by the effect of dipotassium clorazepate and zolpidem in combination with promethazine] [1997.10]
Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern. [1997.06]
Minimal rebound insomnia after treatment with 10-mg zolpidem. [1997.04]
Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery. [1997.03]
Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal. [1996.12]
Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial. [1996.08]
Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters. [1996.06]
Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers. [1996.04]
The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. [1996.03]
Mood effects of zolpidem versus phenobarbital combined with promethazine in an anesthesiological setting. [1996]
Comparative pharmacodynamics of Ro 41-3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects. [1995.11]
[Multidimensional psychometric assessment of preoperative mood. Effects of zolpidem compared to phenobarbital combined with promethazine as premedication] [1995.09]
The acute effects of zolpidem, administered alone and with alcohol, on cognitive and psychomotor function. [1995.07]
Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo. [1995.05]
Antagonizing the effects of experimentally induced sleep disturbance in healthy volunteers by lormetazepam and zolpidem. [1995.04]
Effects of flurazepam and zolpidem on the perception of sleep in insomniacs. [1995.02]
Effect of a single dose (10 mg) of zolpidem on visual and spectral analysis of sleep in young poor sleepers. [1994.11]
Effects of bretazenil vs. zolpidem and placebo on experimentally induced sleep disturbance in healthy volunteers. [1994.11]
|
